Private company
Venus Concept Inc.
American surgical and medical instruments and apparatus company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue32¢$20.5M
- Research and development10¢$6.7M
- Other costs57¢$37.0M
- Income tax1¢$611.0K
Out of $64.8M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $102.6M4 | $110.4M5 | $78.0M6 | $105.6M7 | $99.5M8 | $76.4M3 | $64.8M3 |
| Cost of revenue | $23.3M4 | $33.8M5 | $26.6M5 | $31.5M7 | $33.5M8 | $24.2M3 | $20.5M3 |
| Gross profit | $79.4M4 | $76.7M5 | $51.4M6 | $74.1M7 | $66.0M8 | $52.2M3 | $44.3M3 |
| Research and development | $7.0M4 | $8.0M5 | $7.8M6 | $9.6M7 | $11.0M8 | $8.2M3 | $6.7M3 |
| Operating income | -$3.4M4 | -$30.3M5 | -$67.9M6 | -$14.8M7 | -$34.9M8 | -$28.3M3 | -$27.2M3 |
| Income tax | $2.2M4 | $1.9M5 | $1.2M6 | -$707.0K7 | -$722.0K8 | -$71.0K3 | -$611.0K3 |
| Net income | -$15.0M4 | -$40.6M5 | -$81.7M6 | -$23.0M7 | -$43.7M8 | -$37.2M3 | -$47.0M3 |
| Earnings per share | -$3.164 | -$4.775 | -$2.336 | -$0.427 | -$9.948 | -$68.473 | -$71.213 |
| Earnings per share (diluted) | -$3.164 | -$4.775 | -$2.336 | -$0.427 | -$9.948 | -$68.473 | -$71.213 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $6.7M4 | $15.7M5 | $34.3M6 | $30.9M7 | $11.6M8 | $5.4M3 | $4.3M3 |
| Current assets | $74.6M4 | $99.7M5 | $115.4M6 | $110.5M7 | $84.0M8 | $66.4M3 | $48.5M3 |
| Total assets | $125.1M4 | $191.1M5 | $160.5M6 | $157.4M7 | $125.4M8 | $93.7M3 | $68.2M3 |
| Current liabilities | $30.1M4 | $48.2M5 | $32.5M6 | $34.7M7 | $39.6M8 | $31.2M3 | $30.3M3 |
| Long-term debt | $50.9M4 | $61.2M5 | $75.5M6 | $77.3M7 | $70.0M8 | $70.8M3 | $31.4M3 |
| Total liabilities | $88.7M4 | $114.4M5 | $116.8M6 | $115.8M7 | $116.6M8 | $107.1M3 | $65.3M3 |
| Shareholders’ equity | $32.4M4 | $74.2M5 | $44.2M6 | $40.9M7 | $8.1M8 | -$14.0M3 | $2.4M3 |
| Shares outstanding | 4.8M shares4 | 28.7M shares5 | 53.6M shares6 | 64.0M shares7 | 5.2M shares8 | 552.2K shares3 | 709.1K shares3 |
Leadership
Who has led Venus Concept Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerSilva Rajiv De Oct 4, 2022 to Oct 4, 202211
- Chief executive officerDomenic Serafino Nov 7, 2019 to Feb 7, 202312
- Chief executive officerRyan Rhodes Aug 13, 2018 to Nov 20, 201813
- PresidentHemanth Jacob Varghese Oct 17, 2022 to Nov 22, 202214
- PresidentRoss Portaro Oct 20, 2021 to Nov 22, 202215
- PresidentRyan Rhodes Aug 13, 2018 to Nov 20, 201813
- Chief financial officerPenna Domenic Della Nov 7, 2019 to Nov 14, 202216
- Chief financial officerMark Hair Jan 5, 2018 to Nov 20, 201817
- Chief financial officerCharlotte Holland Oct 11, 2017 to Oct 11, 201718
- Chief operating officerSoren Maor Sinay Nov 7, 2019 to Feb 7, 202319
Board members and other officers (34)
- Exec VP & General ManagerPenna Domenic Della Mar 28, 2023 to Mar 28, 202320
- Exec VP & General ManagerRoss Portaro Mar 28, 2023 to Mar 28, 202321
- VP Global MarketingAnat Kotler Feb 1, 2022 to Feb 7, 202322
- OfficerSilva Rajiv De Nov 22, 2022 to Nov 22, 202223
- VP Regulatory AffairsWilliam H. McGrail Nov 8, 2021 to Mar 28, 202324
- Chief Commercial OfficerChad A. Zaring Feb 13, 2020 to Jun 3, 202125
- VP, Global Human ResourcesAnna Georgiadis Nov 7, 2019 to Mar 28, 202326
- VP, Global MarketingMelissa Kang Nov 7, 2019 to Mar 30, 202127
- VP Clinical & Reg. Affairs, QAYoni Iger Nov 7, 2019 to Feb 7, 202328
- VP, North American SalesChris Aronson Feb 5, 2018 to Nov 20, 201829
- Vice President, Global SalesBrent Nixon Oct 11, 2017 to Oct 11, 201730
- Chief Operations OfficerGabriele Zingaretti Oct 11, 2017 to Nov 20, 201831
- Vice President, MarketingGregory R. Anderson Oct 11, 2017 to Nov 20, 201832
- OfficerRay F. Lee Oct 11, 2017 to Oct 30, 201733
- OfficerRyan Rhodes Oct 11, 2017 to Oct 11, 201734
- Board memberStanley Tyler Hollmig Feb 1, 2022 to Mar 28, 202335
- Board memberSilva Rajiv De Oct 4, 2022 to Oct 4, 202211
- Board memberAnthony Natale Nov 7, 2019 to now36
- Board memberBakker Juliet Tammenoms Nov 7, 2019 to Nov 7, 201937
- Board memberDomenic Serafino Nov 7, 2019 to Aug 31, 202212
- Board memberFritz L. Laporte Nov 7, 2019 to Mar 28, 202338
- Board memberGarheng Kong Nov 7, 2019 to Mar 28, 202339
- Board memberLouise Lacchin Nov 7, 2019 to Mar 28, 202340
- Board memberScott Barry Nov 7, 2019 to Mar 28, 202341
- Board memberKeith J. Sullivan Jul 5, 2018 to Mar 28, 202342
- Board memberCraig C. Taylor Oct 11, 2017 to Jun 15, 201843
- Board memberEmmett Cunningham Oct 11, 2017 to Oct 11, 201744
- Board memberFrederic H. Moll Oct 11, 2017 to Nov 7, 201945
- Board memberGilbert H. Kliman Oct 11, 2017 to Nov 12, 201946
- Board memberJeffrey W. Bird Oct 11, 2017 to Jun 15, 201847
- Board memberRyan Rhodes Oct 11, 2017 to Nov 20, 201834
- Board memberShelley B. Thunen Oct 11, 2017 to Jun 15, 201848
- General counselMichael Mandarello Oct 19, 2021 to Aug 15, 202349
- General counselSisto Domenic Di Nov 7, 2019 to Sep 11, 202050
Former names
Timeline
Filings
382 filings to the SEC since October 2021: 5 annual reports, 13 quarterly reports, 99 major events, 106 insider forms, 50 large holders, 6 private raises, 103 other. The latest 20:
- Apr 9, 2026D EDGAR
- Apr 1, 2026SCHEDULE 13D/A EDGAR
- Mar 30, 2026SCHEDULE 13D/A EDGAR
- Mar 30, 20264 EDGAR
- Mar 27, 2026SCHEDULE 13D/A EDGAR
- Mar 27, 20264 EDGAR
- Mar 18, 2026SCHEDULE 13D/A EDGAR
- Mar 17, 2026SCHEDULE 13D/A EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
- Feb 10, 2026EFFECT EDGAR
The 382 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 50 such filings since October 2021, the latest 10:
- Apr 1, 2026SCHEDULE 13D/A
- Mar 30, 2026SCHEDULE 13D/A
- Mar 27, 2026SCHEDULE 13D/A
- Mar 18, 2026SCHEDULE 13D/A
- Mar 17, 2026SCHEDULE 13D/A
- Jan 15, 2026SCHEDULE 13D/A
- Dec 15, 2025SCHEDULE 13D/A
- Oct 2, 2025SCHEDULE 13D/A
- Jul 2, 2025SCHEDULE 13D/A
- Jun 27, 2025SCHEDULE 13D/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Money raised
Private offerings the company reported to the SEC on Form D.
- Mar 26, 2026Raised $1.5 million in a private offering of equity Form D: 2 investors so far Form D
- Feb 27, 2024Raised $1.1 million in a private offering of securities Form D: 2 investors so far Form D
- May 15, 2023Raised $2 million in a private offering of equity Form D: $9 million offered in all Form D
- Nov 18, 2022Raised $6.7 million in a private offering of equity Form D: 11 investors so far Form D
- Dec 15, 2021Raised $12.3 million in a private offering of equity Form D: 9 investors so far Form D
- Dec 15, 2021Raised $4.7 million in a private offering of equity Form D: 1 investor so far Form D
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARRyan Rhodes, Chief executive officer
- 14SEC EDGARHemanth Jacob Varghese, President
- 15SEC EDGARRoss Portaro, President
- 16
- 17SEC EDGARMark Hair, Chief financial officer
- 18
- 19
- 20
- 21
- 22SEC EDGARAnat Kotler, VP Global Marketing
- 23SEC EDGARSilva Rajiv De, Officer
- 24
- 25
- 26
- 27SEC EDGARMelissa Kang, VP, Global Marketing
- 28
- 29
- 30
- 31
- 32
- 33SEC EDGARRay F. Lee, Officer
- 34SEC EDGARRyan Rhodes, Officer
- 35SEC EDGARStanley Tyler Hollmig, Board member
- 36SEC EDGARAnthony Natale, Board member
- 37
- 38SEC EDGARFritz L. Laporte, Board member
- 39SEC EDGARGarheng Kong, Board member
- 40SEC EDGARLouise Lacchin, Board member
- 41SEC EDGARScott Barry, Board member
- 42SEC EDGARKeith J. Sullivan, Board member
- 43SEC EDGARCraig C. Taylor, Board member
- 44SEC EDGAREmmett Cunningham, Board member
- 45SEC EDGARFrederic H. Moll, Board member
- 46SEC EDGARGilbert H. Kliman, Board member
- 47SEC EDGARJeffrey W. Bird, Board member
- 48SEC EDGARShelley B. Thunen, Board member
- 49SEC EDGARMichael Mandarello, General counsel
- 50SEC EDGARSisto Domenic Di, General counsel